Navigation Links
Pharmatech 2.0: Introducing Pharmatech Oncology
Date:1/5/2009

DENVER, Jan. 5 /PRNewswire/ -- Pharmatech, Inc. announces the launch of a new campaign, Pharmatech 2.0, to highlight the company's focus in oncology, along with other key company developments that will take place in early January 2009. The next generation of Pharmatech will feature a name change from Pharmatech, Inc. to Pharmatech Oncology, Inc., as well as a new web site and emerging roles and responsibilities of the executive leadership team.

With the start of 2009, all business will be managed under the name Pharmatech Oncology, Inc. The Pharmatech Board of Directors implemented the name change from the parent company of Pharmatech, Inc. to the subsidiary name of Pharmatech Oncology. Anders Malm, current President, states, "There was a need in the marketplace for better recognition of what type of business Pharmatech was involved in. Changing from Pharmatech to Pharmatech Oncology relays a core understanding that Pharmatech works within the cancer arena."

The leadership team at Pharmatech Oncology will also be undergoing a transformation in roles and titles. Current Chief Executive Officer, Matthew B. Wiener, PharmD, will now take over the daily business operations under the title Chairman and Chief Operating Officer. Anders Malm, current President, will now replace Dr. Wiener as CEO. Pharmatech Oncology also welcomes Rob Bohacs as the new Corporate Development Manager.

Pharmatech Oncology will also introduce a new web site, http://www.pharmatechoncology.com. The launch of the new web site will showcase a more functional format, along with easy navigation capabilities. The current web site http://www.pharmatech.com will point to the new address at http://www.pharmatechoncology.com.

About Pharmatech Oncology:

Pharmatech Oncology, headquartered in Denver, Colorado, is a Research Management Organization (RMO) dedicated to the highest quality of clinical research. Pharmatech Oncology provides services of a Site Management Organization (SMO) and a Contract Research Organization (CRO) with a focus in oncology clinical trials. Through an organized research network, the Company focuses on the development and utilization of therapeutic products among sponsors, investigators, and patients. For more information about Pharmatech Oncology, please visit www.pharmatechoncology.com.


'/>"/>
SOURCE Pharmatech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. WuXi PharmaTech Will Focus U.S. Operations on Laboratory Testing Services
2. WuXi PharmaTech Appoints Ying Han to Its Board of Directors
3. WuXi PharmaTech Announces Third Quarter 2008 Results
4. WuXi PharmaTech Signs New Collaboration Agreement With Pfizer
5. WuXi PharmaTech Schedules Third Quarter 2008 Earnings Release on Wednesday, November 12, 2008
6. WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance
7. WuXi PharmaTech Appoints Jeff Leng to Its Board of Directors
8. Matthew B. Wiener, CEO of Pharmatech, Inc., Is Awarded the Cancer Leadership Award From the Colorado Cancer Coalition
9. WuXi PharmaTech (NYSE:WX) Maintains Original Strategy to Provide Toxicology Services in China
10. WuXi PharmaTech Promotes Dr. Rujian Ma to VP of Synthetic Chemistry
11. Warburg Pincus Acquires 5.4% of WuXi PharmaTechs Outstanding Ordinary Shares from United Overseas Bank
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... CA (PRWEB) , ... November 30, 2016 , ... ... a new moving magnet Voice Coil Actuator with a flexure design that ensures ... long life with cost-effective pricing and is ideally suited where extreme precision is ...
(Date:11/30/2016)... 2016  The Allen Institute for Cell Science ... publicly available collection of gene edited, fluorescently tagged ... cellular structures with unprecedented clarity. Distributed through the ... are a crucial first step toward visualizing the ... makes human cells healthy and what goes wrong ...
(Date:11/30/2016)... 2016 Part of 5m$ Investment in ... ... Aptuit, LLC today announced that it had successfully completed the ... compounds have increased the Screening Collection to over 400,000. The ... capabilities of the company. This expansion, complemented by new robotics ...
(Date:11/30/2016)... ... November 30, 2016 , ... On 28 November 2016, the International Union of ... nihonium (Nh), moscovium (Mc), tennessine (Ts), and oganesson (Og), respectively for element 113, 115, ... proposed by the discoverers have been approved by the IUPAC Bureau. The IUPAC Council ...
Breaking Biology Technology:
(Date:11/16/2016)... , Nov. 16, 2016 Sensory ... experience and security for consumer electronics, and ... financial and retail industry, today announced a global ... convenient way to authenticate users of mobile banking ... TrulySecure™ software which requires no specialized ...
(Date:11/14/2016)... Nov. 14, 2016  xG Technology, Inc. ("xG" or ... critical wireless communications for use in challenging operating environments, ... 30, 2016. Management will hold a conference call to ... p.m. Eastern Time (details below). Key Recent ... $16 million binding agreement to acquire Vislink Communication Systems. ...
(Date:6/22/2016)... June 22, 2016  The American College of Medical Genetics ... Executive Magazine as one of the fastest-growing trade shows ... at the Bellagio in Las Vegas . ... percentage of growth in each of the following categories: net ... and number of attendees. The 2015 ACMG Annual Meeting was ...
Breaking Biology News(10 mins):